Pregled bibliografske jedinice broj: 1091730
Steatosis assessment by Controlled attenuation parameter in patients with compensated advanced chronic liver disease
Steatosis assessment by Controlled attenuation parameter in patients with compensated advanced chronic liver disease // Liver International, 40 (2020), 7; 1784-1785 doi:10.1111/liv.14426 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1091730 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Steatosis assessment by Controlled attenuation
parameter in patients with compensated advanced
chronic liver disease
(Steatosis assessment by controlled attenuation
parameter in patients with compensated advanced
chronic liver disease)
Autori
Grgurevic, Ivica ; Salkic, Nermin ; Madir, Anita ; Aralica, Gorana
Izvornik
Liver International (1478-3223) 40
(2020), 7;
1784-1785
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
steatosis, CAP, compensated, advanced, chronic, liver, disease
Sažetak
We have read with great interest manuscript by Piccinni et al. in which they demonstrated significant prevalence of liver steatosis in patients with compensated advanced chronic liver disease (cACLD), previously assumed to decrease in advanced fibrosis, as well as very good performance of Controlled attenuation parameter (CAP) in this cohort of patients (1, 2).
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
